|
FY2013
12 months to Oct 31, 2013
|
FY2012
12 months to Oct 31, 2012
|
|
|---|---|---|
| Operating activities | ||
| Net income (loss) | ||
| Income (loss) from continuing operations | ||
| Adjustments to reconcile net income (loss) to cash provided by (used in) operating activities relating to continuing operations(Note 22): | ||
| Items not affecting current cash flows | ||
| Changes in operating assets and liabilities | ||
| Cash provided by operating activities of continuing operations | ||
| Cash provided by operating activities | ||
| Investing activities | ||
| Proceeds from sale of Targeted Therapies | ||
| (Increase) decrease in restricted cash | ||
| Purchase of property, plant and equipment | ||
| Cash provided by (used in) investing activities of continuing operations | ||
| Cash provided by (used in) investing activities | ||
| Financing activities | ||
| Payment of cash dividends | ||
| Repurchase and cancellation of common shares | ||
| Issuance of shares | ||
| Cash used in financing activities of continuing operations | ||
| Cash used in financing activities | ||
| Effect of foreign exchange rate changes on cash and cash equivalents | ||
| Net increase (decrease) in cash and cash equivalents during the year | ||
| Cash and cash equivalents, beginning of year | ||
| Cash and cash equivalents, end of year | ||
| Cash interest paid | ||
| Cash taxes refunded |
Loading...
